US Patent 10407666 Recombinant vectors
Patent 10407666 was granted and assigned to Tocagen on September, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+251 characters)
Article
Patent abstract
This disclosure provides modified cytosine deaminases (CDs). The disclosure further relates to cells and vector expressing or comprising such modified CDs and methods of using such modified CDs in the treatment of disease and disorders.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Christopher R. Logg0
Douglas J. Jolly0
Harry E. Gruber0
Omar D. Perez0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104076660
Date of Patent
September 10, 2019
0Patent Application Number
156720290
Date Filed
August 8, 2017
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10407666 Recombinant vectors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10407666
Date of patent
September 10, 2019
Patent application number
15672029
Date Filed
August 8, 2017
Patent primary examiner
Find more entities like US Patent 10407666 Recombinant vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.